The Pharmaceutical and Laboratory Aspects of Transfusion Medicine

  • W. Wagstaff
Part of the Developments in Hematology and Immunology book series (DIHI, volume 27)


The pharmaceutical aspects of transfusion medicine were brought clearly into perspective in 1985 when EEC Directive number 85/374 established the rights of individuals with regard to the quality of many goods, including blood and its products. As an example of the application of this Directive, in 1987 the United Kingdom Parliament passed the Consumer Protection Act, part I of which was applicable form 1 March 1988 and introduced for the first time the concept of product liability in the field of transfusion medicine. Under this type of legislature, it is no longer necessary for an individual who has been harmed by a product to show that there had been any negligence in its production. As a consequence, most transfusion centres have now taken a structured and organized approach to quality assurance procedures, leading to the assembly of quality systems.


Quality Assurance Quality System Consumer Protection Transfusion Medicine Transfusion Centre 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media Dordrecht 1992

Authors and Affiliations

  • W. Wagstaff

There are no affiliations available

Personalised recommendations